// App-Quantinova.ai

2593 : Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Researchers

Presenter

  • Namshin Kim

Principal Investigators

  • Jong-Ho Won

  • Sung-Hyun Kim

  • Jungwon Huh

  • Nan Young Kim

  • Li Yu

  • Yun Gyeong Lee

  • Sung-Hoon Chung

  • Jae-Sook Ahn

  • Deok-Hwan Yang

  • Je-Jung Lee

  • Dennis Dong Hwan Kim

  • Hyeoung-Joon Kim

  • Quang Trinh

  • Mark D Minden

  • Chul Won Jung

  • Jun-Ho Jang

  • Hee-Je Kim

  • Joon Ho Moon

  • Sang Kyun Sohn

Medical Centers

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada

  • Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu,

Locations

  • Canada

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Fms related tyrosine kinase 3

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim